Max Noble
Menu
CEO Storm Watch · the report4 November 2025

Max Noble

Coloplast

Kristian Villumsen promised 7–9% growth a year and a margin above 30%. Delivered: 7% growth, 28% margin.

🇩🇰 Denmark · Medical devicesColoplast0.0IntegrityKristian VillumsenKristian VillumsenCEO, 2018–2025, ColoplastPromisedhow much profit it keeps from each krone of sales>30% margin; 7–9% growth30 September 2020

Last checked · How I check · Follow this CEO

He promised

Sales would grow 7–9% a year and the margin would be above 30%.

Kristian Villumsen, CEO, 2018–2025, on 30 September 2020.

He got

7% growth and a 28% margin in the final year.

Stamp: Partly kept.

Why, says the company

Product recalls, inflation and acquisitions weighed on profits.

How bad

Near miss. Growth reached only the bottom of the range and the margin goal was missed. The CEO’s Integrity Score went from 0.0 to −2.5.

In the company’s own words

Coloplast named product recalls in Urology and Advanced Wound Care, inflation and higher interest rates that raised input costs, weaker China and the effects of acquisitions. Villumsen stepped down on 5 May 2025; interim CEO Lars Rasmussen reported the final year.

The sources

Last checked 30 October 2026: the sources were opened again and the promise and the stamp still stand. How I check.

Make your call Make your call in The Power Game →

Follow this CEO

Get an email the morning Kristian Villumsen’s card turns.

One email when the stamp changes or a new promise is checked. Nothing else.

Your choices
Your editions
How often
Breaking Briefs

Next: read today’s Morning Brief →